Blood Biomarkers For CNS Disorders
date05 October 2016
time & location12:00PM, Virtual
Hosted By Cambridge Healthtech Institute
Click To Watch As Dr. Henrik Zetterberg And Dr. Jens Kuhle Discuss How Quanterix Simoa Has Enabled Their Research Of Nfl.
Hosted by Cambridge Healthtech Institute, this webinar describes how blood biomarkers can be used to detect CNS disorders. Dr. Henrik Zetterberg discusses the biology of NFL, including selected case studies in neurodegeneration using our Simoa Homebrew technology. You also hear from Dr. Jens Kuhle as he discusses his findings on serum NFL in Multiple Sclerosis using Simoa Technology.
Dr. Henrik Zetterberg
Professor of Neurochemistry and Head of Department at University of Gothenburg, Professor of Neurochemistry at University College London and Senior Consultant in Clinical Chemistry at Sahlgrenska University Hospital
PD Jens Kuhle, MD, PhD
Vice Head Outpatient Clinic and MS Centre, Neurology
University Hospital Basel
Miss the webinar? Click to listen to the full presentation here.